Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Villani

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
European Journal of Dermatology : EJD|June 18, 2025
Hidradenitis suppurativa: a multidisciplinary challenge!Axel Villani
European Journal of Dermatology : EJD|June 18, 2025
Hidradenitis suppurativa: pathogenesisAxel Villani
La Revue Du Praticien|December 2, 2015
[Drug hypersensitivity: definitions and mechanisms]Axel Villani, Pascal Demoly, Jean-François Nicolas
Journal of the American Academy of Dermatology|October 21, 2018
Tumor necrosis factor-α inhibitors for the treatment of pyoderma gangrenosum not associated with inflammatory bowel diseases: A multicenter retrospective studyLaurie Rousset, Adèle de Masson, Edouard Begon, et al.
Clinical and Experimental Dermatology|January 26, 2023
Treatment of dissecting cellulitis of the scalp with tumour necrosis factor inhibitors: a retrospective multicentre studyMuslih Alzahrani, Victor Coste, Maria Polina Konstantinou, et al.
Dermatology Research and Practice|April 2, 2020
Long-Term Infliximab Treatment in Psoriasis Patients: A National Multicentre Retrospective StudyClémentine Carlet, Damien Bichard, Marie Aleth Richard, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
European Journal of Dermatology : EJD|June 18, 2025
Hidradenitis suppurativa: a multidisciplinary challenge!Axel Villani
European Journal of Dermatology : EJD|June 18, 2025
Hidradenitis suppurativa: pathogenesisAxel Villani
La Revue Du Praticien|December 2, 2015
[Drug hypersensitivity: definitions and mechanisms]Axel Villani, Pascal Demoly, Jean-François Nicolas
Journal of the American Academy of Dermatology|October 21, 2018
Tumor necrosis factor-α inhibitors for the treatment of pyoderma gangrenosum not associated with inflammatory bowel diseases: A multicenter retrospective studyLaurie Rousset, Adèle de Masson, Edouard Begon, et al.
Clinical and Experimental Dermatology|January 26, 2023
Treatment of dissecting cellulitis of the scalp with tumour necrosis factor inhibitors: a retrospective multicentre studyMuslih Alzahrani, Victor Coste, Maria Polina Konstantinou, et al.
Dermatology Research and Practice|April 2, 2020
Long-Term Infliximab Treatment in Psoriasis Patients: A National Multicentre Retrospective StudyClémentine Carlet, Damien Bichard, Marie Aleth Richard, et al.
Pageof 1